<DOC>
	<DOCNO>NCT00958048</DOCNO>
	<brief_summary>Specific aim : Aim 1 . To determine incidence hypoventilation Amyotrophic Lateral Sclerosis ( ALS ) patient . Aim 2 . To identify clinical characteristic risk factor associate . Aim 3 . To determine effect early intervention nocturnal NIV prognosis ALS patient .</brief_summary>
	<brief_title>Effects Nocturnal Non-invasive Ventilation Patients With Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Objectives : Amyotrophic lateral sclerosis common motor neuron disease incidence 0.8 person-years Chinese . Respiratory muscle function propose strong predictor quality life ( QoL ) survival ALS . Some study suggest patient ALS develop hypoventilation vital capacity ( FVC ) less 50 % predict value . However , incidence hypoventilation factor associate hypoventilation ALS patient clear . Also , still consensus physiologic marker use trigger initiation non-invasive ventilation ( NIV ) ALS patient . The conflict study come variable subgroup ALS , pulmonary function enrollment , technique use diagnose ALS , time apply NIV , target endpoint . Therefore , project aim study ALS patient relatively preserve respiratory muscle function respiratory failure clinical achieve three goal : ( 1 ) To determine incidence hypoventilation ALS patient ( 2 ) To identify clinical characteristic risk factor associate hypoventilation ALS patient ( 3 ) To determine effect early intervention NIV prognosis ALS patient Study design : Randomized , control trial Participants : ALS patient whose FVC 40 % -80 % predict , Pimax &lt; 60mmHg , daytime PaCO2 &lt; 50mmHg Protocol : Eligible patient whole-night polysomnography ( PSG ) transcutaneous CO2 ( PtcCO2 ) . Enrolled patient randomized standard treatment NIV . The primary endpoint prognosis survival . The secondary endpoint change PtcCO2 PaCO2 , unexpected admission clinic visiting , daytime function QoL . Statistic : The baseline demographic patient without hypoventilation compare determine factor associate hypoventilation ALS patient . The impact NIV ALS patient determine compare primary secondary goal standard treatment NIV group . A two-sided p value &lt; 0.05 consider statistically significant . Clinical implication : Hypoventilation ALS patient relatively preserve respiratory muscle function respiratory failure clinical sleep common , early identification PSG screen PtcCO2 allow early diagnosis intervention . Understanding time apply NIV effect prognosis ALS allow early intervention prediction outcome .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>ALS patient : FVC 40 % 80 % predict Pimax &lt; 60 mmHg daytime PaCO2 &lt; 50 mmHg Refuse participate Require mechanical ventilation Active neurologic event ALS Obstructive pulmonary disease Active infection Need sedatives narcotic within 3 day sleep study Participating study time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>hypoventilation</keyword>
</DOC>